Light-Activated gel shows promise for psoriasis skin relief
NCT ID NCT05442190
Summary
This study tested a new topical ointment called SGX302, which is activated by visible light, to see if it could improve skin lesions in people with mild-to-moderate plaque psoriasis. Fifteen participants applied the treatment to their skin for an 18-week course. The main goal was to see how many people achieved skin that was 'Clear' or 'Almost Clear' of psoriasis signs.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Therapeutics Clinical Research
San Diego, California, 92123, United States
Conditions
Explore the condition pages connected to this study.